<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02078583</url>
  </required_header>
  <id_info>
    <org_study_id>PEKING SEDATION</org_study_id>
    <nct_id>NCT02078583</nct_id>
  </id_info>
  <brief_title>The Effect of Analgesia Based Sedation Protocol on Brain Function of Critical Care Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University People's Hospital</source>
  <brief_summary>
    <textblock>
      Benzodiazepines is a commonly uesd sedative medication,there are many reports that&#xD;
      Benzodiazepines is associated with delirium ,but using of analgesia reduces benzodiazepines&#xD;
      requirements .The purpose of this study is to determine whether analgesia based sedation&#xD;
      protocol reduces the incident of delirium.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>July 2014</start_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence and duration of delirium in patients with different regimens</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator-free days</measure>
    <time_frame>an expected average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean days of mechanical ventilation</measure>
    <time_frame>an expected average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>an expected average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Index of anesthesia depth monitoring</measure>
    <time_frame>From admission to ICU to weaning,about 7 days</time_frame>
    <description>Analgesic level、sedation level、brain function、 blood perfusion for peripheral and brain circulation、sleep stages and variation of blood volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infusion velocity and total dose of sedative drugs in different groups</measure>
    <time_frame>From admission to ICU to extubation or drug withdrawal,about 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma melatonin level</measure>
    <time_frame>Every 6 hours during the next ICU day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total rescue dose of midazolam</measure>
    <time_frame>Seven days after giving midazolam to patient</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variations of HR、RR、BP、SpO2</measure>
    <time_frame>an expected average of 7 days</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Delirium</condition>
  <arm_group>
    <arm_group_label>Remifentanil，midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Remifentanil 1µg/kg/hr intravenous pump and Midazolam loading dose 0.05mg/kg followed by 0.02~0.1mg/kg/h continuous intravenous pump for 7days or extubation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fentanyl，midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fentanyl 1µg/kg/hr intravenous pump and Midazolam loading dose 0.05mg/kg followed by 0.02~0.1mg/kg/h continuous intravenous pump for 7days or extubation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline1µg/kg/hr intravenous pump and Midazolam loading dose 0.05mg/kg followed by 0.02~0.1mg/kg/h continuous intravenous pump for 7days or extubation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <arm_group_label>Fentanyl，midazolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <arm_group_label>Remifentanil，midazolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <arm_group_label>Normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Signing a consent form&#xD;
&#xD;
          -  postoperative patient&#xD;
&#xD;
          -  Requirement for mechanical ventilation and anticipate time of mechanical ventilation&#xD;
             more than 24 hours&#xD;
&#xD;
          -  Requirement for sedation&#xD;
&#xD;
          -  Age more than 18 and less than 85 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unstable blood circulation&#xD;
&#xD;
          -  Heart rate less than 50 beats per minute&#xD;
&#xD;
          -  II ° ～ III ° atrioventricular conduct block&#xD;
&#xD;
          -  Intracranial lesions 、neurosurgical intervention and mental disability inability to&#xD;
             cooperate;&#xD;
&#xD;
          -  Receipt of antipsychotics 、hypnotic drugs before surgery ;&#xD;
&#xD;
          -  Alcohol abuse;&#xD;
&#xD;
          -  Liver failure class Child-Pugh C;&#xD;
&#xD;
          -  Acute Respiratory Distress Syndrome;&#xD;
&#xD;
          -  Acute or chronic renal failure;&#xD;
&#xD;
          -  Other severe diseases ,septic shock;&#xD;
&#xD;
          -  Receipt of neuromuscular blocking drug;&#xD;
&#xD;
          -  Pregnancy and nursing woman;&#xD;
&#xD;
          -  Allergy to investigational drug or other contraindication.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dan Liu, Resident physician</last_name>
    <phone>+8613811365572</phone>
    <email>fancyjuice@126.com</email>
  </overall_contact>
  <verification_date>July 2014</verification_date>
  <study_first_submitted>February 28, 2014</study_first_submitted>
  <study_first_submitted_qc>March 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2014</study_first_posted>
  <last_update_submitted>July 15, 2014</last_update_submitted>
  <last_update_submitted_qc>July 15, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

